Tribunal exempts 3,5-Xylenol from customs duty, citing pharmaceutical status.

The Tribunal ruled in favor of the appellant, determining that 3, 5-Xylenol qualified as a pharmaceutical chemical entitled to exemption from the levy of additional duty of customs under the relevant notification. The decision was supported by references to authoritative sources and previous Tribunal decisions, establishing the pharmaceutical nature of 3, 5-Xylenol and its derivatives. As a result, the appeals were allowed, and consequential relief was directed to be granted within a specified timeframe.

---

---

Issues:
Whether 3, 5-Xylenol imported by the appellant was entitled to exemption from the levy of additional duty of customs in terms of Notification No. 55/75-Central Excises dated 1-3-1975.

Detailed Analysis:

The appeals were initially filed as revision applications before the Central Government and were transferred to the Tribunal for disposal as appeals. The issue involved in both appeals was the entitlement of 3, 5-Xylenol to exemption from the levy of additional duty of customs under a specific notification. The appeals were heard together due to the similarity of the issue.

The main issue revolved around whether 3, 5-Xylenol could be considered a drug intermediate entitled to exemption as per the relevant notification. The appellant argued that previous Tribunal decisions favored their position, while the Department contended that the chemical was not a drug or drug intermediate, as it was used in antiseptic and germicidal preparations, not as a pharmaceutical.

The appellant's counsel relied on references from the British Pharmacopoeia to establish that 3, 5-Xylenol and its derivatives, PCMX and DCMX, were used in pharmaceuticals as antiseptics and germicides. The Tribunal considered these arguments and previous decisions on the same substance before reaching a conclusion.

The Tribunal referred to authoritative sources like Hawle's "Condensed Chemical Dictionary" and definitions of "pharmaceutical" to determine that 3, 5-Xylenol was indeed a pharmaceutical chemical. The chemical's use in medicine, as evidenced by its derivatives' properties and applications, supported the conclusion that it fell within the scope of the exemption notification.

Ultimately, the Tribunal decided in favor of the appellant, allowing both appeals and directing the grant of consequential relief within a specified timeframe. The decision was based on the established pharmaceutical nature of 3, 5-Xylenol and its derivatives, aligning with previous Tribunal rulings on the matter.

---